Thus, MMP-1 and MMP-3 transcripts were apparently decreased after treatment with sorafenib (Fig. 5g), providing a possible explanation for its potent roles on controlling KF migration as well as tumor cell invasion and metastasis. The gene discussed is AFMID; the disease is neoplasm.